08.03.2014 Views

14th ICID - Poster Abstracts - International Society for Infectious ...

14th ICID - Poster Abstracts - International Society for Infectious ...

14th ICID - Poster Abstracts - International Society for Infectious ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

When citing these abstracts please use the following reference:<br />

Author(s) of abstract. Title of abstract [abstract]. Int J Infect Dis 2010;14S1: Abstract number.<br />

Please note that the official publication of the <strong>International</strong> Journal of <strong>Infectious</strong> Diseases 2010, Volume 14, Supplement 1<br />

is available electronically on http://www.sciencedirect.com<br />

Final Abstract Number: 23.019<br />

Session: Antibiotic Resistance Gram-Negative<br />

Date: Wednesday, March 10, 2010<br />

Time: 12:30-13:30<br />

Room: <strong>Poster</strong> & Exhibition Area/Ground Level<br />

Type: <strong>Poster</strong> Presentation<br />

Extended spectrum beta-lactamases in Escherichia coli and Klebsiella spp. from Eastern<br />

Romania<br />

E. Miftode 1 , O. Dorneanu 2 , D. Leca 3 , A. Teodor 4 , A. Badescu 5 , G. Juganariu 5 , A. Vita 5 , C.<br />

Dorobat 5<br />

1 Univ. of Medicine and Pharmacy - Hospital of <strong>Infectious</strong> Diseases, Iasi, Romania, 2 Univ Medicine<br />

and Pharmacy Iasi, Iasi, Romania, 3 Univ. of Medicine and Pharmacy, Iasi, Romania, 4 Univ of<br />

Medicine and Pharmacy, Iasi, Romania, 5 Univ Medicine and Pharmacy, Iasi, Romania<br />

Background: The emergence and dissemination of ESBL are problems of major importance <strong>for</strong><br />

the population health; ESBLs represent a first example of factor that contribute to the global crisis<br />

concerning the treatment of Klebsiella pneumoniae and Escherichia coli against which the third<br />

generation cephalosporins are not efective anymore.<br />

Methods: Clinically isolates of E. coli (n= 642) and Klebsiella (n=92 ) were collected from patients<br />

with different types of infections (sepsis, urinary tract infections, etc), hospitalyzed between<br />

september 08 and september 09 in a Hospital of <strong>Infectious</strong> Diseses from Eastern Romania.<br />

Double disc synergy test using cefotaxime and amoxicillin/clavulanic acid discs was used to<br />

screen ESBL producers and these strains were subsequently subjected to confirmatory Etest.<br />

Results: E. coli resistance to cefotaxime, ceftazidime, cefoxitin, ciprofloxacin and imipenem was<br />

found to be 40, 29, 6, 30 and 1% respectively. Klebsiella resistance to cefotaxime, ceftazidime,<br />

cefoxitin, ciprofloxacin and imipenem was 70, 57, 22, 41 and 4% respectively. % of ESBL<br />

producers E. coli was 15% (97 strains) and Klebsiella was 38% (35). All the ESBL producing<br />

strains were susceptible in 100% to imipenem and meropenem.<br />

Conclusion: Carbapenems remain the most active agents against Gram-negative isolates,<br />

including ESBL producers strain of E. coli and Klebsiella spp. isolated from community-acquired<br />

and nosocomial infections from Eastern Romania.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!